Cdc20 may serve as a potential biomarker-based risk score system in predicting the prognosis of patients with hepatocellular carcinoma

HIGHLIGHTS

SUMMARY

    Hepatocellular carcinoma (HCC) is a familiar form and approximately 90% of all the liver cancers. Biomarkers of miRNAs, genes, and lncRNAs have previously been reported in HCC patients. The liver is an important organ in terms of immunity, where HCC cells can inhibit the immune system, leading to tumor cell proliferation and immunodeficiency. The immune microenvironment has been recognized to promote HCC metastasis and development, which has been shown to be correlated with poor prognosis in HCC. In this study, HCC tissues and adjacent nontumor tissues are used to analyze through a bioinformatics analysis . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?